Zymeworks Inc.

IPO

Making a Meaningful Difference — Zymeworks

Public · $65.0M raised

Business Model
B2B
Total Funding
$65.0M
Last Round
$61.5M Venture RoundJan 2015
Rounds
2
Type
Public

About

Royalty-driven biotechnology company developing novel multifunctional medicines for difficult-to-treat cancers and serious diseases.

Summary

Zymeworks Inc. is a Biotech company. It has raised $65.0M in total across 2 rounds, most recently a $61.5M Venture Round round in Jan 2015. Investors include Royalty Pharma and BDC Venture Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Debt FinancingDebt FinancingJan 2024
$250.0M

Sign up to see all 4 rounds

Series A through Debt Financing — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Zymeworks Inc. on Indexed.vc
<a href="https://indexed.vc/companies/zymeworks-inc"><img src="https://indexed.vc/api/badge/company/zymeworks-inc" alt="Zymeworks Inc. on Indexed.vc" width="260" height="76" /></a>